The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond.
3EO Health licenses Wyss Institute technology from Harvard, aiming to develop at-home molecular testing with PCR-grade sensitivity and antigen test–level cost streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond.
CytoTronics Launches with $9 25 Million in Seed Funding to Revolutionize Drug Discovery and Phenotypic Screening streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.